Audited Financial Results for the Quarter and year ended on 31.03.2026
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 28 May 2026, 05:49 PM IST · BSE ID: f55afbe1-c8cb-4823-a7d8-f3ce104bf691
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported higher quarterly and annual profits, appointed a new director, and approved a manufacturing deal for medicines.
🤖 AI Summary
- Vasundhara Rasayans Ltd. reported a Net Profit of Rs. 247.82 Lakhs for Q4 FY26, a 455.33% increase from Rs. 44.63 Lakhs in Q4 FY25.
- For the full financial year ended March 31, 2026, Net Profit was Rs. 578.91 Lakhs, up 36.33% from Rs. 424.63 Lakhs in FY25.
- The Board appointed Mr. Ravi Jain as an Additional Director (Non-executive Independent Director) and reconstituted the Audit, Nomination, and Stakeholders Relationship Committees.
- An MoU cum Loan-Lease Agreement with Pand J Cretechem Private Limited (Holding Company) for API manufacturing was approved.
- Earnings Per Share (Basic & Diluted) for FY26 stood at Rs. 18.22, compared to Rs. 13.36 in FY25.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit (Q4 FY26)
Rs. 247.82 Lakhs
455.33%
Net Profit (FY26)
Rs. 578.91 Lakhs
36.33%
Total Income (FY26)
Rs. 3,862.69 Lakhs
6.29%
EPS (Basic & Diluted, FY26)
Rs. 18.22
36.38%
Paid-up Equity Share Capital
Rs. 317.82 Lakhs
🏢 How This Affects the Company
The approved MoU cum Loan-Lease Agreement for API manufacturing with the Holding Company indicates a strategic move into Active Pharmaceutical Ingredients production, potentially expanding the company's product portfolio and market reach.
The significant increase in net profit for both Q4 FY26 and the full financial year FY26 demonstrates improved financial performance, contributing to stronger earnings.
The manufacturing arrangement at the Holding Company's facility in Dahej, Gujarat, expands Vasundhara Rasayans' operational capabilities for API production.
No immediate increase or decrease in risk is directly discernible from the financial results or the operational arrangement disclosed in this filing.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the improved financial performance and the strategic expansion into API manufacturing, which could influence the company's future value.
🔍
Management Signal
Management is signaling a focus on growth and diversification, evidenced by strong financial results and the strategic entry into Active Pharmaceutical Ingredients production.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarterly results for Q1 FY27 to assess continued financial performance.
Further updates on the API manufacturing arrangement with Pand J Cretechem Private Limited.
Details on the execution and progress of the MoU cum Loan-Lease Agreement.
LOW RISK
The filing reports strong financial performance and a strategic business expansion without indicating new immediate risks.
💡 Investor Takeaway
Vasundhara Rasayans Ltd. reported Q4 FY26 Net Profit of Rs. 247.82 Lakhs, a 455.33% increase YoY. Full-year FY26 Net Profit grew 36.33% to Rs. 578.91 Lakhs. The company also approved an MoU for API manufacturing with Pand J Cretechem Private Limited.
⚖️ Strengths & Concerns
✅ Positives
- Q4 FY26 Net Profit increased 455.33% to Rs. 247.82 Lakhs from Rs. 44.63 Lakhs in Q4 FY25, indicating strong quarterly performance.
- FY26 Net Profit grew 36.33% to Rs. 578.91 Lakhs from Rs. 424.63 Lakhs in FY25, reflecting robust annual profitability.
⚠️ Concerns
- Cost of materials consumed for FY26 decreased to Rs. 1,474.92 Lakhs from Rs. 1,562.75 Lakhs in FY25, while total income increased, suggesting potential shifts in input costs or procurement strategies.
- Other Expenses for Q4 FY26 increased to Rs. 324.26 Lakhs from Rs. 248.78 Lakhs in Q4 FY25, indicating higher operational overheads during the quarter.
📅 Company Track Record
Past filings (2026-05-28) indicated Vasundhara Rasayans Q4 FY26 Net Profit at Rs. 247.82 Lakhs and FY26 profit up 36.33%, aligning with the detailed audited results now released.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Vasundhara Rasayans' net profit for the fourth quarter ended March 31, 2026?
Vasundhara Rasayans Ltd.'s net profit for Q4 FY26 was Rs. 247.82 Lakhs, a 455.33% increase from Rs. 44.63 Lakhs in Q4 FY25.
What was Vasundhara Rasayans' full-year net profit for the financial year ended March 31, 2026?
For the full financial year ended March 31, 2026, Vasundhara Rasayans Ltd. reported a net profit of Rs. 578.91 Lakhs, up 36.33% from Rs. 424.63 Lakhs in FY25.
Did Vasundhara Rasayans Ltd. make any new director appointments?
Yes, Mr. Ravi Jain (DIN: 11720815) was appointed as an Additional Director (Non-executive Independent Director) with effect from May 28, 2026.
What strategic agreement did Vasundhara Rasayans Ltd. approve?
Vasundhara Rasayans Ltd. approved a Memorandum of Understanding cum Loan-Lease Agreement with Pand J Cretechem Private Limited for a manufacturing arrangement of Active Pharmaceutical Ingredients (APIs).
What was the Basic & Diluted Earnings Per Share (EPS) for Vasundhara Rasayans in FY26?
The Basic & Diluted Earnings Per Share for Vasundhara Rasayans Ltd. in FY26 was Rs. 18.22, compared to Rs. 13.36 in FY25.
Questions based on this BSE filing only. For information purposes.